Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in systemic therapies for advanced prostate cancer.

BMJ (Clinical research ed.)·2026
Same author

Pancreatic resection for metastatic renal cell carcinoma: outcomes in the era of immunotherapy and targeted therapy.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Mapping Microvascular Flow via Radon Transform Ultrasound: Technical Advances and Pilot Application.

BME frontiers·2026
Same author

Postpartum Exercise Promotes Maternal-Infant Molecular Communication via Breast Milk Small Extracellular Vesicles.

medRxiv : the preprint server for health sciences·2026
Same author

Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0.

Journal of extracellular vesicles·2026
Same author

Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial.

BJU international·2026

Related Experiment Video

Updated: Sep 3, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Radiation Therapy in Oligometastatic Prostate Cancer.

Siven Chinniah1, Bradley Stish2, Brian A Costello3

  • 1Mayo Clinic Alix School of Medicine, Rochester, Minnesota.

International Journal of Radiation Oncology, Biology, Physics
|July 25, 2022
PubMed
Summary
This summary is machine-generated.

Radiation therapy (RT) shows promise for metastatic prostate cancer, particularly in oligometastatic disease and when combined with metastasis-directed therapy. Future research may explore RT

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.4K

Related Experiment Videos

Last Updated: Sep 3, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.4K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urologic Oncology

Background:

  • Prostate cancer (PCa) presents a spectrum from localized to metastatic disease.
  • Radiation therapy (RT) is standard for early PCa and palliation, but its survival benefit in metastatic settings is less defined.
  • Oligometastatic disease and metastasis-directed therapy (MDT) represent evolving treatment paradigms.

Purpose of the Study:

  • To review evidence for localized RT in oligometastatic prostate cancer.
  • To examine metastasis-directed therapy (MDT) in hormone-sensitive and hormone-resistant PCa.
  • To explore RT's future role as an immune-sensitizing therapy and the impact of advanced imaging.

Main Methods:

  • Systematic review of existing literature on RT and MDT for metastatic prostate cancer.
  • Analysis of studies investigating RT in oligometastatic and polymetastatic disease.
  • Discussion of emerging concepts in RT, immunotherapy, and advanced imaging for PCa.

Main Results:

  • Evidence suggests localized RT may benefit select patients with oligometastatic prostate cancer.
  • MDT shows potential in both hormone-sensitive and hormone-resistant metastatic PCa.
  • Highly sensitive imaging is crucial for identifying candidates for RT in metastatic disease.

Conclusions:

  • RT, particularly in conjunction with MDT, holds potential for improving outcomes in metastatic prostate cancer.
  • Future integration of RT as an immune-sensitizing agent warrants investigation.
  • Advances in imaging are critical for optimizing RT application in advanced PCa.